Kintara Therapeutics is a clinical stage company that develops anti-cancer therapies for cancer patients, with two late-stage therapies in development, VAL-083 and REM-001. VAL-083, which targets drug-resistant solid tumors including glioblastoma multiforme, along with non-small cell lung cancer and ovarian cancer, has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. REM-001 is a photodynamic therapy used to treat cutaneous metastatic breast cancer.